Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Commission To Look Into 'Skyrocketing' EU Drug Prices, Availability, and Patient Access

Executive Summary

The European Commission, at the request of member state health ministers, is to run an analysis of the effect of incentives such as data exclusivity and supplementary protection certificates on drug prices, availability and access to medicines. Ministers have also given their backing to further voluntary cooperation initiatives among countries to rein in what they see as the very high prices of some medicines.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

SC065450

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel